Topic: Women biopharma executives
Despite advances in life sciences and the corporate world, professional women still face numerous hurdles, even those at the top of their fields.
June Bray, Senior Vice President of Regulatory Affairs and Medical Writing, Allergan
Melissa Moore, Chief Scientific Officer, Research Platform, Moderna Therapeutics
Things are looking up—or so they seem. In the era of #MeToo, more women are speaking up about workplace harassment and discrimination. Industry groups and states are pushing for more women to be included on corporate boards. But in a way, these advances only highlight the hurdles women still face, even women at the top of their fields.
Susan Sweeney, Head of Worldwide Commercialization, Bristol-Myers Squibb
Rebecca Holland New, Group VP, Global Business Management, Thermo Fisher
Andrea Spezzi, Chief Medical Officer and Co-founder, Orchard Therapeutics
Marion Dorsch, Chief Scientific Officer, Blueprint Medicines
Shalini Sharp, Chief Financial Officer, Ultragenyx
Beth-Ann Coller, executive director of project management and leadership at Merck.